Cancer statistics, 2026 Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes u....

Declining mortatlity rates in cancer, with greatest gain in lung cancer. Continued investment in research is critical for this trend to continue. #endcancer
acsjournals.onlinelibrary.wiley.com/doi/10.3322/...

Making progress on our new research building @mdanderson.bsky.social. #endcancer #OnlyPossibleHere

Rb1 deficiency induces synthetic lethality with ATR and PKMYT1 coinhibition in breast cancer cell lines and patient-derived xenografts ATR/PKMYT1 coinhibition induces synthetic lethality in Rb1-deficient breast cancers, supporting biomarker-guided therapy.

Inhibition of ATR and PKMYT1 induces synthetic lethality in RB1-deficient #BreastCancer. Important implications for pts resistant to CDK4/6 inhibitors. @mdanderson.bsky.social #EndCancer
www.science.org/doi/10.1126/...

Researchers at MD Anderson discovered a promising therapeutic pathway for a challenging subtype of acute myeloid leukemia that uses a combination of therapies.

Read more: spr.ly/63320CeB4E #OncSky #EndCancer

Bingo wishes everyone a most joyous #holiday season!

Radiation induces cell death through copper overload suggesting new therapeutic strategies for cancer pts. #radonc #endancer #cuproptosis @mdanderson.bsky.social
www.cell.com/cancer-cell/...
www.sciencedirect.com/science/arti...

My fav #ornament.

Annual holiday ornament exchange for the ⁦‪@MDAnderson.bsky.social‬⁩ Division Heads. May the holiday season bring everyone joy and peace. #endcancer

Journal launch enables oncology education and quality improvement An interest in process improvement projects and learning from others led radiation oncologist Shalin Shah, M.D., to help launch MD Anderson’s first academic journal, Advances in Cancer Education and Quality Improvement (ACE-QI).

How do you improve cancer care without reinventing the wheel?

A first-of-its-kind journal launched at MD Anderson is helping teams share real-world education and quality improvement projects with clinicians around the world. Read more. spr.ly/63327CuOx1 #OncSky #EndCancer

I always enjoy getting together with this group of #radonc leaders @mdanderson.bsky.social. #endcancer

What an inspiring day to walk with our patients, colleagues, and supporters. @mdanderson.bsky.social Boot Walk to #EndCancer. Still have time to contribute #OnlyPossibleHere

mdanderson.donordrive.com/participants...

Excited to attend
@mdanderson.bsky.social’s Campaign to #EndCancer. Only Possible Here.

Any guesses regarding where is this location?

Parents weekend at Brown University!

Exploiting metabolic cell death for cancer therapy Nature Reviews Cancer - In this Review, Mao et al. discuss the regulation and interplay of the metabolic cell death pathways ferroptosis, disulfidptosis and cuproptosis and explore how these...

Excited to share our review of metabolic cell death pathways relevant for cancer therapy. @mdanderson.bsky.social #endcancer

rdcu.be/eK7vV

Yup. Only about half our faculty could make it.

Annual @mdanderson.bsky.social #radonc faculty photo. #endcancer
Can you spot who is missing?

📢 Excited to share our new pub @JCO_ASCO

ascopubs.org/doi/10.1200/...

✅We report late colorectal cancer dose-response models for colorectum RT dose and chemo

#radonc #medphys #survivorship
@MDAndersonNews

That's a wrap! Another #ASTRO25 in the books. Great catching up with everyone. See you in Boston for #ASTRO26! #radonc #endcancer @mdanderson.bsky.social

Hanging out with the @mdanderson.bsky.social #radonc residents at the after party. #ASTRO25

Global Outreach If you are ready to make an appointment, select a button on the right. If you have questions about MD Anderson's appointment process, our information page may be the best place to start.

"MD Anderson is committed to extending our reach to improve cancer care globally," says @schmeler.bsky.social during her #ASTRO25 presentation on identifying international partners when setting up a global oncology program.

Learn more: spr.ly/6013A5Rzf #EndCancer

Find out about our latest #radonc research to #endcancer. See you at #ASTRO25.

4 things I learned from my radiation oncology training at MD Anderson After completing his radiation oncology residency at MD Anderson and joining the faculty, Vincent Bernard-Pagan, M.D., Ph.D., shares what he learned from his training and what sets MD Anderson apart for trainees.

"Without this network of mentorship and institutional support, I would not be in the position I am today as a physician-scientist leading my own laboratory," says our Dr. Vincent Bernard-Pagan.

His insights from radiation oncology training: spr.ly/63325AbA5H #OncSky #EndCancer

Targeted radiation helps patients with kidney cancer delay systemic therapy  Targeted radiation helps patients with kidney cancer delay systemic therapy 

Targeted radiation gave patients with oligometastatic kidney cancer a median of nearly 3 years without systemic therapy while maintaining high survival. A ctDNA biomarker may help personalize this approach. spr.ly/63320ADVdQ #OncSky #EndCancer

Congrats to these ⁦‪@MDAnderson.bsky.social‬⁩ #radonc faculty for their achievements in these areas. Amazing work to #endcancer!

Congrats to Dr. Prajnan Das for this recognition. This is one of the highest honors bestowed upon @mdanderson.bsky.social faculty. #endcancer #radonc

Most recent ranking of scientific journals from Google scholar.
scholar.google.com/citations?vi...

Thrilled to announce that after a highly competitive national search, Dr. Prajnan Das has been selected as the inaugural chair of GIRO Department @mdanderson.bsky.social . Looking forward to all the great things he will do in this new role. #rad onc #endcancer

Defeated by the grad students in the inaugural @mdanderson.bsky.social #foosball tournament at Zayed. Junjie Chen and I will need to step up our game next year! #radonc #endcancer

Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy | NEJM The benefit of regional nodal irradiation in the treatment of breast cancer is well established for patients with pathologically positive axillary nodes, but whether it is also beneficial for patie...

Subset analysis reveals regional nodal irradiation may be omitted in AXLN pos breast CA with pCR after neoadj chemo. Less may be more. @ibcradiation.bsky.social @fumikochino.bsky.social #radonc
www.nejm.org/doi/10.1056/...